Hemo Organic quarterly results and financials

Hemo Organic (BSE 524590)₹20.99−3.94%(2 Nov 2026 close)Trading & Distributors

Key facts

In the Jun 2026 quarter (standalone), Hemo Organic reported sales of ₹0 Cr and net profit of −₹0.06 Cr. For the year to Mar 2026, sales were ₹0.94 Cr and net profit −₹0.79 Cr.

Sales (Jun 2026): ₹0 Cr
Net profit (Jun 2026): −₹0.06 Cr
Sales (FY Mar 2026): ₹0.94 Cr
Net profit (FY Mar 2026): −₹0.79 Cr
EPS (Jun 2026): ₹−0.21
Borrowings (Mar 2026): ₹2.73 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Hemo Organic quarterly results

₹ crore unless stated; each column is a quarter.

Hemo Organic Quarterly results
	Jun 2023	Sep 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.00	0.00	0.03	0.00	0.00	2.42	0.00	0.00	0.00	0.94	0.00
Expenses	0.03	0.00	0.22	0.07	0.07	2.25	0.10	0.03	0.04	1.22	0.06
Operating Profit	−0.05	0.02	−0.22	−0.09	−0.09	0.16	−0.12	−0.05	−0.06	−0.31	−0.08
OPM %	—	—	−1,050.0%	—	—	6.2%	—	—	—	−32.3%	—
Other Income	0.00	0.00	0.00	0.00	0.00	0.10	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	−0.03	0.00	−0.22	−0.07	−0.07	0.23	−0.10	−0.03	−0.04	−0.29	−0.06
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	−58.4%	−27.3%	−25.0%	219.9%	69.9%	0.0%
Net Profit	−0.05	0.02	−0.24	−0.09	−0.07	0.38	−0.08	−0.02	−0.17	−0.52	−0.06
EPS (Rs)	−0.13	0.04	−0.67	−0.24	−0.24	1.08	−0.27	−0.10	−0.47	−1.48	−0.21

Hemo Organic profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Hemo Organic Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.12	0.61	0.10	0.06	0.28	0.02	0.02	0.00	0.03	2.42	0.94	0.94
Expenses	0.15	0.67	0.23	0.16	0.28	0.05	0.06	0.04	0.25	2.44	1.42	1.35
Operating Profit	−0.06	−0.09	−0.16	−0.13	−0.03	−0.06	−0.07	−0.06	−0.25	−0.05	−0.51	−0.50
OPM %	−45.4%	−13.3%	−166.7%	−240.0%	−7.4%	−500.0%	−600.0%	—	−1,200.0%	−1.7%	−53.8%	−53.2%
Other Income	−0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.08	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.00	0.00	0.00
Depreciation	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	−0.81	−0.07	−0.14	−0.11	−0.01	−0.04	−0.05	−0.04	−0.25	0.02	−0.49	−0.42
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	−466.7%	55.9%	—
Exceptional items	−1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	−0.83	−0.09	−0.16	−0.13	−0.03	−0.06	−0.05	−0.04	−0.27	0.17	−0.79	−0.77
EPS (Rs)	−2.38	−0.24	−0.44	−0.36	−0.07	−0.15	−0.18	−0.15	−0.76	0.47	−2.26	−2.26
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Hemo Organic balance sheet

₹ crore, at each year end.

Hemo Organic Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.41	3.41	3.48	3.48	3.48	3.48	3.48	3.48	3.48	3.48	3.48	3.48
Reserves	−2.16	−2.99	−3.07	−3.21	−3.33	−3.36	−3.40	−3.46	−3.52	−3.78	−3.63	−3.35
Borrowings	0.05	0.00	0.00	0.07	0.07	0.00	0.03	0.03	0.03	1.23	1.47	2.73
Other Liabilities	0.09	0.12	0.73	0.67	0.74	0.14	0.13	0.20	0.36	0.14	3.67	1.61
Total Liabilities	1.39	0.54	1.14	1.01	0.96	0.26	0.24	0.25	0.35	1.07	4.99	4.47
Fixed Assets	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	0.46	0.54	1.14	1.01	0.96	0.26	0.24	0.25	0.35	1.07	4.99	4.47
Inventories	0.00	0.00	0.02	0.03	0.00	0.00	0.00	0.03	0.01	0.00	1.43	0.50
Trade receivables	0.14	0.00	0.71	0.71	0.73	0.06	0.06	0.05	0.05	0.07	2.51	2.38
Cash & equivalents	0.07	0.09	0.08	0.04	0.01	0.02	0.02	0.00	0.11	0.12	0.02	0.86
Total Assets	1.39	0.54	1.14	1.01	0.96	0.26	0.24	0.25	0.35	1.07	4.99	4.47

Hemo Organic cash flow

₹ crore, for each year.

Hemo Organic Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.05	−0.77	−0.14	−0.11	−0.03	0.00	0.00	0.10	−1.18	−0.35	−1.45
Cash from investing activity	0.00	0.69	0.01	0.05	0.03	0.00	0.00	0.00	0.00	0.00	−0.85
Cash from financing activity	0.00	0.09	0.16	0.00	0.00	0.00	0.00	0.00	1.21	0.25	2.33
Net cash flow	0.06	0.00	0.00	−0.05	0.00	0.00	0.00	0.10	0.00	−0.11	0.00
Free cash flow	0.05	−0.06	−0.14	−0.11	−0.03	0.00	0.00	0.10	−1.18	−0.35	−1.45
CFO / OP %	−67.0%	1,560.0%	188.0%	80.0%	33.0%	−50.0%	20.0%	−220.0%	496.0%	900.0%	292.0%

Hemo Organic ratios

Working-capital days and returns, by year.

Hemo Organic Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	343	0	439	2,921	5,403	96	2,556	2,191	—	1,461	383	939
Inventory days	0	0	20	90	0	0	0	729	—	—	142	199
Days payable	—	—	392	3,010	—	—	—	4,014	—	—	365	611
Cash conversion cycle	342	0	66	0	5,402	95	2,555	−1,095	—	1,460	159	526
Working capital days	115	233	147	690	439	−67	−1,824	−4,014	—	11,864	157	786
ROCE %	−7.8%	−12.9%	−19.3%	−40.1%	−42.9%	−11.8%	−43.5%	−75.1%	−250.0%	−52.2%	2.6%	−23.9%

Hemo Organic: frequently asked questions

What are the latest quarterly results of Hemo Organic?

For the Jun 2026 quarter, Hemo Organic reported sales of ₹0 Cr and net profit of −₹0.06 Cr.

What is the annual revenue of Hemo Organic?

Hemo Organic's sales for the year to Mar 2026 were ₹0.94 Cr; over the last twelve months they were ₹0.94 Cr.

What is the net profit of Hemo Organic?

Net profit for the year to Mar 2026 was −₹0.79 Cr, and −₹0.77 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−2.26.

How much debt does Hemo Organic have?

Hemo Organic reported borrowings of ₹2.73 Cr at Mar 2026, against cash and equivalents of ₹0.86 Cr.

What is the free cash flow of Hemo Organic?

Cash from operations was −₹1.45 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.45 Cr.

Loading…